| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 27 May 2025 | 20 May 2025 |
| Parnax Lab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2025 inter alia to consider and approve Standalone and Consolidated Audited IND- AS Compliant Financial Results along with Auditor Report for the quarter (Q4) and Year ended 31st March 2025 pursuant to Regulation 33 of Listing Obligation and Disclosure Requirement 2015. Please find enclosed herewith the Audited Financial Results for the Quarter and Year Ended March 31, 2025. (As Per BSE Announcement Dated on: 27/05/2025) | ||
| Board Meeting | 10 Feb 2025 | 31 Jan 2025 |
| PARNAX LAB LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2025 inter alia to consider and approve Standalone and Consolidated Un-audited IND- AS Compliant Financial Results along with Limited Review Report for the quarter (Q3) and Nine Months ended 31st December 2024 and to approve the notice of Postal Ballot Appointment of Mr. Vijay Ayare as an Additional Director (Non-Executive Independent Director) of the Company Outcome of Board Meeting dated 10th February, 2025 (As Per BSE Announcement dated on 10.02.2025) | ||
| Board Meeting | 14 Nov 2024 | 6 Nov 2024 |
| PARNAX LAB LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2024 inter alia to consider and approve Standalone and Consolidated Un-audited IND- AS Compliant Financial Results along with Limited Review Report for the quarter (Q2) and half year ended 30th September 2024 pursuant to Regulation 33 of Listing Obligation and Disclosure Requirement 2015. Change in Designation of Directors of the Company PFA herewith the Unaudited Financial Results for the Quarter and Half Year Ended September 30, 2024 (As per BSE Announcement Dated on 14/11/2024) | ||
| Board Meeting | 14 Aug 2024 | 5 Aug 2024 |
| PARNAX LAB LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2024 inter alia to consider and approve 1. Standalone and Consolidated Un-audited IND- AS Compliant Financial Results along with Limited Review Report for the quarter (Q1) and three months ended 30th June 2024 pursuant to Regulation 33 of Listing Obligation and Disclosure Requirement 2015. 2. To decide the date of the Annual General Meeting of the Company for the Financial Year ended 31st March 2024; 3. Any other business with the permission of the Chair. Board Meeting Outcome for Approval of Unaudited Financial Standalone and Consolidated Results for the Quarter Ended June, 2024. (As per BSE Announcement Dated on 14/08/2024) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.